US Senator Urges Investigation into Prime, Labeling It a "Significant Health Concern"

US Senator Calls for FDA Investigation into Energy Drink Brand Prime Over Health Concerns

US Senator Urges Investigation into Prime, Labeling It a "Significant Health Concern"
Energy Drink Brand Prime Over Health Concerns

Controversy surrounds the popular energy drink brand Prime as a US senator has taken action by writing a letter to the Food and Drug Administration (FDA), urging them to launch an investigation. The concerns primarily revolve around the drink's impact on the young audience of prominent figures KSI and Paul. In one instance, a school in Wales issued a warning to parents after a student experienced a "cardiac episode" following consumption of Prime.

Democratic US Senator Charles Schumer has voiced his alarm about Prime's caffeine levels and called for an FDA inquiry, stating that the drink poses a significant health risk. The Associated Press reported on July 9, 2023, that Schumer emphasized the need to investigate Prime, given its popularity among children and adolescents who form a significant portion of KSI and Paul's fanbase.

Prime is marketed as an energy drink with no added sugar and contains 200 mg of caffeine per can, surpassing the caffeine content of other popular brands like Red Bull and Monster. The high caffeine concentration has raised concerns, leading schools in the UK and elsewhere to ban its consumption among students. Schumer highlighted the potential confusion between Prime Energy, not recommended for children under 18 as per the website FAQ, and Prime Hydration, which is caffeine-free. Parents, unaware of the distinction, may mistakenly give their children a highly caffeinated beverage.

While it remains to be seen if the FDA will proceed with the investigation, Prime has captured the attention of members of the US Congress, indicating the significance of the issue at hand. Stay updated by subscribing to our newsletter for the latest developments in Esports, Gaming, and more.

Next Article